AVEO Related Earnings News
-
Notable Winners and Losers from Q1 Earnings Season: (YRCW) (TSLA) (AVEO) (CRMB)
-
AVEO Pharma's (AVEO) Tivozanib Needs Second Trial; Leerink Swann Comments
-
AVEO Pharmaceuticals (AVEO) Posts Q1 Loss of 69c/Share
-
Jefferies Cuts PT on AVEO Pharmaceuticals (AVEO); More Cautious on Tivo Approval
-
AVEO Pharmaceuticals (AVEO) Tops Q4 EPS by 28c, Offers Guidance
-
AVEO Pharmaceuticals (AVEO) Posts Narrower than Expected Q3 Loss of 69c; Has Capital Through FY13
-
AVEO Oncology (AVEO) Announces Restructuring; Will Explore Ficlatuzumab Development Via Collaboration
-
Some Surprise Gainers, Losers Show Up Following Q2 Results (FSLR) (MTG) (SVNT) (ZNGA)
-
Jefferies Downgrades AVEO Pharmaceuticals (AVEO) to Hold; Regulatory Risk Rises
-
AVEO Pharmaceuticals (AVEO) Posts Narrower than Expected Q2 Loss; Maintains Outlook
-
Canaccord Genuity Maintains a 'Buy' on AVEO Pharmaceuticals (AVEO); Q1 In-line; Waiting on P3 TIVO-1 Data at ASCO
-
AVEO Pharmaceuticals (AVEO) Reports In-Line Q1 Loss of 77c/Share
-
AVEO Pharmaceuticals (AVEO) Tops Q4 EPS by 3c
-
AVEO Pharmaceuticals, Inc. (AVEO) Reports In-Line Q3 Loss; Revs Light
-
AVEO Pharma (AVEO) Posts Narrower than Expected Q2 Loss
-
AVEO Pharma (AVEO) Blows Up Q1 Views
-
AVEO Pharma (AVEO) Posts Narrower than Expected Q4 Loss; Revs Strong
-
AVEO Pharma (AVEO) Posts Mixed Q2 Results
Back to AVEO Stock Lookup
